Company Filing History:
Years Active: 2014
Title: David J Schneider: Innovator in Ischemic Event Prevention
Introduction
David J Schneider is a notable inventor based in Colchester, Vermont, who has made significant contributions to the field of medicine. His work primarily focuses on methods for treating and preventing ischemic events, particularly in patients undergoing percutaneous coronary intervention (PCI). With a patent to his name, Schneider's innovations aim to enhance patient outcomes in critical medical situations.
Latest Patents
Schneider holds a patent titled "Methods of treating, reducing the incidence of, and/or preventing ischemic events." This patent outlines a method for administering a pharmaceutical composition that includes cangrelor to patients undergoing PCI. The method may also involve the use of an additional therapeutic agent, such as a P2Y inhibitor. The patent emphasizes the importance of pharmaceutical compositions that can effectively treat or prevent ischemic events, which may include stent thrombosis, myocardial infarction, ischemia-driven revascularization, and mortality.
Career Highlights
Throughout his career, David J Schneider has worked with prominent companies in the pharmaceutical industry, including The Medicines Company and Chiesi Farmaceutici S.p.a. His experience in these organizations has contributed to his expertise in developing innovative solutions for medical challenges.
Collaborations
Schneider has collaborated with notable professionals in his field, including Clive Arthur Arculus-Meanwell and Simona Skerjanec. These collaborations have likely enriched his research and development efforts, leading to advancements in the treatment of ischemic events.
Conclusion
David J Schneider's contributions to the medical field through his patent and collaborations highlight his commitment to improving patient care. His innovative methods for preventing ischemic events represent a significant advancement in medical treatment.